NOVACYT |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.656 EUR | -2.53% |
|
-15.57% | -7.99% |
| May. 30 | EARNINGS AND TRADING: TPXimpact expects growth; Novacyt loss widens | AN |
| May. 30 | Novacyt: losses widen in 2023, share price falls | CF |
Novacyt develops, produces, and sells in vitro and molecular diagnostic products for the microbiology, haematology and serology markets. The activity is organized around two sectors:
- development of solutions and diagnostic services. The group is also developing a manufacturing activity for reagents and kits for bacterial and blood tests;
- manufacture and sale of molecular screening kits (Primerdesign): for laboratories.
Calendar
2024-06-26
- Annual General Meeting
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -7.99% | 50.21M | |
| -25.27% | 120M | |
| -12.28% | 64.19M | |
| +0.27% | 57.13M | |
| +1.20% | 53.15M |
- Stock Market
- Equities
- ALNOV Stock
- Funds and ETFs Novacyt
